GSK to test Tycerb for head and neck cancer

March 7, 2007
Sales and Marketing breast cancer

GlaxoSmithKline is to trial its potential blockbuster Tycerb for a new indication in head and neck cancer.Tycerb was only submitted …

Merck lung cancer vaccine enters phase III trials

March 7, 2007
Research and Development

A therapeutic vaccine for the most common form of lung cancer has enrolled its first patient into global phase III …

Academy launched to fill NHS training need

March 7, 2007
NHS

Training and development company Excel Communications has launched a new initiative to allow pharma companies to sponsor courses for doctors.The …

Eisai prepares for Inovelon UK launch

March 7, 2007
Sales and Marketing

Eisai is preparing to launch its new epilepsy treatment Inovelon in the UK after European regulators approved it in January.Managing …

Work begins on Eisai’s Knowledge Centre

March 7, 2007
Research and Development, Sales and Marketing

Eisai is a step nearer to getting its £100 million European base up and running after it broke ground at …

Pfizer’s controversial new UK supply chain goes live

March 5, 2007
Manufacturing and Production

Pfizer has launched its new single wholesaler supply chain in the UK, after a last-minute legal challenge was defeated.The pharmaceutical …

PR: messages from the frontline

March 5, 2007
Medical Communications, Sales and Marketing public relations, strategy

Media rationalisation & technology"Here is the news but not as we know it! The media landscape is constantly evolving as …

Prime Minister opens Amgen European R&D centre

March 2, 2007
Research and Development

Prime Minister Tony Blair has opened Amgen's new European Development Centre in Uxbridge, London.The centre is the Californian biotech company's …

Sales data specialists Cegedim to buy rivals Dendrite

March 2, 2007
Sales and Marketing Cegedim

French specialist pharmaceutical database and software company Cegedim is to buy its US-based rivals Dendrite for $751 million.Dendrite's board of …

New clinical trials network to boost patient recruitment in UK

March 2, 2007
Research and Development

Thousands more patients are set to be enrolled on clinical trials in primary care in the UK, thanks to the …

Novartis’ 2-in-1 blood pressure drug Exforge launched in the UK

March 2, 2007
Sales and Marketing

Novartis new hypertension drug Exforge has been launched in the UK, promising to help more patients lower their blood pressure …

Court orders withdrawal of generic Lipitor in Denmark

March 2, 2007
Sales and Marketing

Pfizer has gained a court injunction ordering the withdrawal of a generic version of its top-seller Lipitor (atorvastatin).Indian generics company …

Two products fuelling Actelion’s growth spurt

March 2, 2007
Sales and Marketing

Swiss specialist pharma company Actelion saw sales revenue rise 43% in 2006 thanks to rapid growth in its two products, …

US approval for Shire’s Vyvanse

February 28, 2007
Sales and Marketing

Shire and New River Pharmaceuticals have been given the green light by the FDA to market anti-ADHD drug Vyvanse. Shire, …

Helping UK pharma communicate

February 28, 2007
Medical Communications, Sales and Marketing HCA, assocation, public relations

The Healthcare Communications Association (HCA), which aims to promote excellence and best practice within pharmaceutical industry communications, has reached its …

Radical overhaul of NHS prescription drug prices recommended

February 20, 2007
Sales and Marketing pricing

 The Office of Fair Trading wants to reform the way prescription medicines are priced to reflect the benefits they bring …

Learning from Northwick Park

February 19, 2007
Research and Development UK, biotech, clinical trials, drug safety

In December 2006, the official report on the Northwick Park incident was published. Although not the end of the affair, …

Doctors attack ‘nonsensical’ NHS cost-cutting

February 19, 2007

The British Medical Association has branded as "nonsensical" the situation whereby hospitals delay routine operations because of financial problems.The doctors' …

Pfizer to submit evidence to NICE inquiry

February 16, 2007
Sales and Marketing

Pfizer has confirmed that it is to submit evidence to a forthcoming inquiry into the workings of NICE.The Commons Health …

Sanofi-Aventis growth stifled by Plavix and price cuts

February 15, 2007
Sales and Marketing

Figures show that Sanofi-Aventis continued to grow in 2006, despite its complaints about pressure in the US from generic manufacturers …

The Gateway to Local Adoption Series

Latest content